Business growth

Roche has received FDA approval for the emergency use of the RT-PCR test cobas® SARS-CoV-2 and influenza A/B for fully automated and widely available cobas® 6800 and cobas® 8800 systems. The test not only identifies the presence of the virus, but also distinguishes influenza from coronavirus, which is especially important as the flu season approaches. It will help health professionals to correctly diagnose and choose an effective treatment method.